Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Healthtrust
Covington
Deloitte
Novartis
UBS
Fish and Richardson
McKinsey
Baxter
Cantor Fitzgerald

Generated: February 23, 2018

DrugPatentWatch Database Preview

NADOLOL Drug Profile

« Back to Dashboard

When do Nadolol patents expire, and what generic alternatives are available?

Nadolol is a drug marketed by Amneal Pharms Co, Aurobindo Pharma Ltd, Invagen Pharms, Ivax Sub Teva Pharms, Lupin Ltd, Mylan, Sandoz, Teva Pharms, Zydus Pharms Usa Inc, and Impax Labs. and is included in twelve NDAs.

The generic ingredient in NADOLOL is bendroflumethiazide; nadolol. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the bendroflumethiazide; nadolol profile page.

US Patents and Regulatory Information for NADOLOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan NADOLOL AND BENDROFLUMETHIAZIDE bendroflumethiazide; nadolol TABLET;ORAL 078688-002 Feb 15, 2008 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Zydus Pharms Usa Inc NADOLOL nadolol TABLET;ORAL 207761-003 Jul 28, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Impax Labs NADOLOL AND BENDROFLUMETHIAZIDE bendroflumethiazide; nadolol TABLET;ORAL 077833-001 Mar 30, 2007 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Amneal Pharms Co NADOLOL nadolol TABLET;ORAL 208832-001 Jun 2, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan NADOLOL nadolol TABLET;ORAL 074172-002 Oct 31, 1993 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Pharms NADOLOL nadolol TABLET;ORAL 074368-002 Aug 31, 1994 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Invagen Pharms NADOLOL nadolol TABLET;ORAL 203455-002 Dec 18, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aurobindo Pharma Ltd NADOLOL nadolol TABLET;ORAL 201893-001 Sep 16, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ivax Sub Teva Pharms NADOLOL nadolol TABLET;ORAL 074255-002 Jan 24, 1996 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz NADOLOL nadolol TABLET;ORAL 074501-001 Nov 9, 1995 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
McKesson
Express Scripts
Colorcon
Chinese Patent Office
Deloitte
Moodys
Accenture
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot